In addition, since it has been reported that MEL18 deficiency leads to the reduction of estrogen receptors, which results in hormone-sensitive breast cancer cells acquiring the ability to grow in a hormone-independent manner [20], C1orf50 may have a vital role in hormone insensitivity in Luminal breast cancer patients. This evidence concerns the gene PCGF2 and breast cancer.